Infectious Disease Prevention Group : Update on vaccines, 2022
Copyright © 2022. Publicado por Elsevier España, S.L.U..
The update of the preventive activities for this year 2022 in the field of infectious diseases is of special relevance due to the importance that prevention has gained and more specifically, vaccination as a tool to control the pandemic caused by the SARS-CoV-2 virus declared on March 11, 2020. The pandemic has focused much of the prevention efforts on its containment, but the importance of maintaining high vaccination coverage of the rest of the recommended vaccines to maintain good control of vaccine-preventable diseases and avoid complications in particularly vulnerable patients should not be forgotten. In this year's review we present a practical document with the aim of providing tools to primary care professionals who work with adults, to make the indication of each vaccine whether it is systematically recommended or if it is because the patient belongs to some risk group due to their condition or underlying pathology. In this way, throughout the document, we will comment on the most innovative aspects of systematic vaccination (flu, pneumococcus, meningococcal vaccines and vaccines against the human papillomavirus [HPV]), the new vaccines (pandemic vaccines against COVID-19, vaccines against herpes zoster of subunits, vaccines against monkeypox) and the recommended vaccines according to risk condition (pregnancy and lactation, travelers, patients with immunosuppression or underlying pathology).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:54 Suppl 1 |
|---|---|
| Enthalten in: |
Atencion primaria - 54 Suppl 1(2022) vom: 25. Okt., Seite 102462 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Prevención de las enfermedades infecciosas. Actualización en vacunas PAPPS 2022 |
|---|
| Beteiligte Personen: |
Martín Martín, Susana [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 29.11.2022 Date Revised 02.11.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.aprim.2022.102462 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM349484910 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM349484910 | ||
| 003 | DE-627 | ||
| 005 | 20231226042732.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.1016/j.aprim.2022.102462 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1164.xml |
| 035 | |a (DE-627)NLM349484910 | ||
| 035 | |a (NLM)36435581 | ||
| 035 | |a (PII)S0212-6567(22)00182-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Martín Martín, Susana |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Infectious Disease Prevention Group |b Update on vaccines, 2022 |
| 246 | 3 | 3 | |a Prevención de las enfermedades infecciosas. Actualización en vacunas PAPPS 2022 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.11.2022 | ||
| 500 | |a Date Revised 02.11.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022. Publicado por Elsevier España, S.L.U. | ||
| 520 | |a The update of the preventive activities for this year 2022 in the field of infectious diseases is of special relevance due to the importance that prevention has gained and more specifically, vaccination as a tool to control the pandemic caused by the SARS-CoV-2 virus declared on March 11, 2020. The pandemic has focused much of the prevention efforts on its containment, but the importance of maintaining high vaccination coverage of the rest of the recommended vaccines to maintain good control of vaccine-preventable diseases and avoid complications in particularly vulnerable patients should not be forgotten. In this year's review we present a practical document with the aim of providing tools to primary care professionals who work with adults, to make the indication of each vaccine whether it is systematically recommended or if it is because the patient belongs to some risk group due to their condition or underlying pathology. In this way, throughout the document, we will comment on the most innovative aspects of systematic vaccination (flu, pneumococcus, meningococcal vaccines and vaccines against the human papillomavirus [HPV]), the new vaccines (pandemic vaccines against COVID-19, vaccines against herpes zoster of subunits, vaccines against monkeypox) and the recommended vaccines according to risk condition (pregnancy and lactation, travelers, patients with immunosuppression or underlying pathology) | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Actividades preventivas | |
| 650 | 4 | |a Atención primaria | |
| 650 | 4 | |a Enfermedades infecciosas | |
| 650 | 4 | |a Infectious diseases | |
| 650 | 4 | |a Preventive activities | |
| 650 | 4 | |a Primary care | |
| 650 | 4 | |a Vaccination of the adult | |
| 650 | 4 | |a Vacunación del adulto | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Vaccines |2 NLM | |
| 700 | 1 | |a Morató Agustí, M Luisa |e verfasserin |4 aut | |
| 700 | 1 | |a Javierre Miranda, Ana Pilar |e verfasserin |4 aut | |
| 700 | 1 | |a Sánchez Hernández, Coro |e verfasserin |4 aut | |
| 700 | 1 | |a Schwarz Chavarri, Germán |e verfasserin |4 aut | |
| 700 | 1 | |a Aldaz Herce, Pablo |e verfasserin |4 aut | |
| 700 | 1 | |a García Iglesias, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Gómez Marco, José Javier |e verfasserin |4 aut | |
| 700 | 1 | |a Gutiérrez Pérez, M Isabel |e verfasserin |4 aut | |
| 700 | 0 | |a Grupo de Prevención de Enfermedades Infecciosas del PAPPS |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Atencion primaria |d 1991 |g 54 Suppl 1(2022) vom: 25. Okt., Seite 102462 |w (DE-627)NLM012612324 |x 1578-1275 |7 nnns |
| 773 | 1 | 8 | |g volume:54 Suppl 1 |g year:2022 |g day:25 |g month:10 |g pages:102462 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.aprim.2022.102462 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 54 Suppl 1 |j 2022 |b 25 |c 10 |h 102462 | ||